A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.
about
Improving access to novel agents for childhood leukemia.Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomasImpact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway.Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia.Novel therapy for childhood acute lymphoblastic leukemia.Acute lymphoblastic leukemia: a comprehensive review and 2017 updateNovel agents for the treatment of childhood leukemia: an update.Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.Suppression of miR-708 inhibits the Wnt/β-catenin signaling pathway by activating DKK3 in adult B-all.Mixed-phenotype acute leukemia treated with decitabine.Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL.Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia.Low-dose decitabine enhances chidamide-induced apoptosis in adult acute lymphoblast leukemia, especially for p16-deleted patients through DNA damage.New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress.Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements.
P2860
Q35688742-26C23ECC-8D9B-404B-860F-52A6EFD309B9Q36703448-EADA8496-FC8C-4AC0-97CA-CD37D562BAAAQ38572855-382B2395-6D68-4053-AF02-8649164910A6Q38819975-FD7C3FBD-71E8-441A-B790-D4844720330AQ38833038-CAAF79A5-0290-4A06-8A35-5A08CBDF1989Q38835910-AA14FB4B-C5AB-4B8D-845B-63781087FDB2Q38838983-ED01ADE1-7291-478B-B4E3-DBE125ED30ACQ38973962-E53BBB94-3F5A-45E8-A191-7F4BC99B33F7Q39368957-A472A9AB-94AE-4DD2-9131-238557163DB7Q39406969-51ECECA8-0D0B-4C10-8D4A-5722B7E69516Q39455649-50A490D5-885C-4120-AEB1-6F87720682B0Q41612823-691BAD45-0140-409E-AF99-2F9B902061BEQ41940928-0FF83610-B75A-4677-BA09-C8CC75C5BCF3Q42617189-C71F26CD-FF4C-4F1A-8B50-A5084408D9D2Q47559681-2F901AAE-351E-4D60-82DC-3B7592230554Q50159067-2E4F3B41-0983-4EE4-8FF5-3ED1733A1A49Q51813512-D63B42B9-AB2C-4683-81BA-AA7993866E19Q51835906-9E530FFC-CB95-4177-A1EE-082AF51D17A6Q51839566-208F84E8-5ED3-42F8-BA26-EA430CA0C1B6Q53814000-AE54FAD0-C1A3-4A1F-974A-10A7C510E7B0Q55018427-2B33799C-F5B7-42E6-9ECD-E6F3D2BE37A8
P2860
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@ast
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@en
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@nl
type
label
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@ast
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@en
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@nl
prefLabel
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@ast
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@en
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
A therapeutic trial of decitab ...... acute lymphoblastic leukemia.
@en
P2093
Brenda J Weigel
Bruce R Lindgren
Jatinder K Lamba
Michael J Burke
Michael R Verneris
Xueyuan Cao
Yogita Ghodke-Puranik
P2860
P304
P356
10.1002/AJH.23778
P577
2014-06-27T00:00:00Z